Cargando…
Efficacy of arbidol in COVID-19 patients: A retrospective study
BACKGROUND: To date, no treatment has proven to be absolutely effective for coronavirus disease 2019 (COVID-19) patients, and further research is necessary. As a traditional antiviral drug, arbidol was widely used in Wuhan at the beginning of the COVID-19 epidemic and is of increasing interest for t...
Autores principales: | Wei, Shuo, Xu, Sha, Pan, Yun-Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464471/ https://www.ncbi.nlm.nih.gov/pubmed/34616801 http://dx.doi.org/10.12998/wjcc.v9.i25.7350 |
Ejemplares similares
-
Clinical features of elderly patients with COVID-19 in Wuhan, China
por: Wei, Shuo, et al.
Publicado: (2022) -
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
por: Fang, Jie, et al.
Publicado: (2020) -
Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study
por: Luo, Shun-Kui, et al.
Publicado: (2021) -
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
por: Yang, Chunguang, et al.
Publicado: (2020) -
Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)